All Keywords
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment
[Category] COVID19(2023년),
[Source] pubmed
Communicable Diseases Research
감염병 연구데이터